EMEA-000311-PIP05-17-M02
Key facts
| Invented name |
Stelara
|
| Active substance |
Ustekinumab
|
| Therapeutic area |
Gastroentology-Hepatology
|
| Decision number |
P/0281/2020
|
| PIP number |
EMEA-000311-PIP05-17-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of ulcerative colitis
|
| Route(s) of administration |
|
| Contact for public enquiries |
Janssen Cilag International NV
Tel. +3214602111 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|